Videos

Mary Golf, PharmD, discusses the latest in research options for CLL management.

Officials unveiled the world's first robot with closed system transfer device (CSTD), dubbed the Equashield® Pro, at the ASHP Midyear Meeting held here earlier this month.

The industry has accepted that CSTDs were created to prevent deficiencies that exist when compounding with needles and syringes, including the escape of hazardous drug via leakage, aerosol, and vapor.

Take a minute to watch and share with your patients, if only for the cute pictures of kittens and puppies.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how to improve the relationship between specialty pharmacies and specialty drug manufacturers.

A PGY-2 Oncology Residency Director shares her advice for residents about remaining adaptable.

Pharmacists must adjust their counseling approaches as more treatment options become available for patients with cancer.

A Memorial Sloan-Kettering pharmacist discusses the often complicated reimbursement process for oncology medications and appeals.

A hematology/oncology clinical pharmacist with Memorial Sloan-Kettering Cancer Center discusses the importance of early collaboration between pharmacists and oncologists in patient care.

Third-generation medications for epilepsy are improving treatment options.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The Director of Pharmacy Services at Peninsula Regional Medical Center, chats with Pharmacy Times adding another layer of safety to compound parental nutrition doses.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses what pharmacists should keep in mind when treating patients with epilepsy.

Sterile compounding is very important for pharmacies.

Marc Scheetz, PharmD, MS, BCPS-AQ ID, associate professor at Midwestern University and clinical pharmacist at Northwestern Medicine, discusses antimicrobial stewardship.

Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.

William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty pharmacies can navigate limited distribution networks.

Tracy Glauser, MD—associate director of Neurology, Cincinnati Children's Hospital Medical Center—discusses the role of bioinformatics in health care.

Joseph Sullivan, MD—associate professor at the University of California San Francisco, director of USCF Pediatric Epilepsy Center—discusses some of the challenges in managing pediatric epilepsy.

Mitra Habibi, PharmD, discusses the challenges in treating patients with multiple comorbidities.

​Fred Massoomi, PharmD, discusses compounding options.

Petrea Cober, PharmD, BCNSP, BCPPS, discusses the challenges of parenteral nutrition education.

Arching Shrestha, MD, discusses the challenges of treating epilepsy in the elderly.

Sanjeev V. Thomas, MD, DM, FANA—professor of neurology, chairman of the Epilepsy Program, Sree Chitra Tirunal Institute—discusses why the risk of seizures is higher for women during the peripartum period.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy and classification of seizures differ from the previous versions.

Christopher M. Jones, PharmD, CDR, US Public Health Service, discusses opportunities for pharmacists to reduce opioid prescription rates.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy may change the disease.

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses treatment options for patients with epilepsy due to tuberous sclerosis complex.